Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Int J Pharm ; 645: 123410, 2023 Oct 15.
Article de Anglais | MEDLINE | ID: mdl-37703958

RÉSUMÉ

Transdermal drug delivery system (TDDS) was an effective way to realize controlled drug delivery. However, realizing zero-order controlled drug skin delivery was still challenging in the drug-in-adhesive patch. This study provided a strategy to accomplish this delivery form by stabilizing the drug concentration in adhesive through concentration-dependent competitive interaction. Clonidine (CLO) and Granisetron (GRA) were chosen as the model drugs which were of high skin permeability, and polydimethylaminoethyl acrylate (EA) as an excipient to interact with hydroxyphenyl adhesive (HP). Drug release, permeation and pharmacokinetic study were conducted to evaluate the controlled effect of HP-EA. The molecular interaction was characterized by FT-IR, 1H NMR and XPS. Dynamic simulation and molecular docking further clarified the competitive interaction involved in the release process. Both the drug skin permeation study of CLO and GRA patch based on the HP-EA adhesive showed good zero-order fitting with r of 0.994 and 0.998, compared with non-functional adhesive (0-PSA). Furthermore, the pharmacokinetic study of the CLO patch showed a plateau phase for around 52 h without influencing the area under concentration-time curve (AUC), indicating that the HP-EA could realize zero-order drug skin delivery. The mechanism study revealed that EA serving as a 'buffer component' promoted the conversion of the ionic CLO to the neutrals the as the neutrals released, which stabilized '1% neutrals CLO concentration'. In conclusion, the drug delivery system based on the concentration-dependent competitive interaction broadened our understanding of the molecular mechanisms involved in zero-order controlled release in transdermal patches which would promote the development of zero-order drug delivery in TDDS.


Sujet(s)
Absorption cutanée , Peau , Simulation de docking moléculaire , Spectroscopie infrarouge à transformée de Fourier , Peau/métabolisme , Administration par voie cutanée , Adhésifs/composition chimique , Libération de médicament , Patch transdermique
2.
Opt Express ; 31(7): 11717-11728, 2023 Mar 27.
Article de Anglais | MEDLINE | ID: mdl-37155800

RÉSUMÉ

In this paper, we propose a multiple images simultaneous encryption scheme by encrypting the orbital angular momentum (OAM) holography with ghost imaging. By controlling the topological charge of the incident OAM light beam on the OAM-multiplexing hologram, different images can be selectively obtained for ghost imaging (GI). Followed by the random speckles illumination, the bucket detector values in GI are obtained and then considered as the ciphertext transmitted to the receiver. The authorized user can distill the correct relationship between the bucket detections and the illuminating speckle patterns with the key and the additional topological charges, so that each holographic image can be successfully recovered, while the eavesdropper can not obtain any information about the holographic image without the key. The eavesdropper even can not get clear holographic image when all the key is eavesdropped but without topological charges. The experimental results show that the proposed encryption scheme has a higher capacity for multiple images because there is no theoretical topological charge limit for the selectivity of OAM holography, and the results also show that the proposed encryption scheme is more secure and has a stronger robustness. Our method may provide a promising avenue for multi-image encryption and has the potential for more applications.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE